PET-CT with Gallium 68 (DOTA) in the United Arab Emirates typically costs from $1,800 to $3,000. The final price depends on the specific radiotracer used and the clinic location. In the US, this specialized diagnostic costs about $4,700 on average. Patients in the UAE save approximately 49% compared to US prices.
Bookimed Expert Insight: Choosing a quaternary care center in Abu Dhabi provides access to high-level clinical expertise. Burjeel Medical City (BMC) maintains JCI and Temos accreditations for international patient standards. This facility employs over 200 Western-board-certified physicians for precise scan interpretation. Dr. Sadir Alrawi leads oncology services here after training at the NCI-designated Roswell Park Cancer Institute. Such expertise is vital for staging complex neuroendocrine tumors accurately.
| United Arab Emirates | Turkey | Austria | |
| PET-CT with Gallium 68 (DOTA) | ≈ $1,800 | from $1,700 | ≈ $1,500 |
No hidden fees – just official clinic prices. Pay at the clinic for PET-CT with Gallium 68 (DOTA) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in PET-CT with Gallium 68 (DOTA) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your PET-CT with Gallium 68 (DOTA) journey.
Dr. Sadir Alrawi is a board-certified surgical oncologist. He specializes in upper gastrointestinal, head and neck, minimally invasive, breast, and colorectal cancers. He also has expertise in heated chemoperfusion. Dr. Alrawi serves as the Director of Oncology Services at VPS Hospital system in the UAE and MENA region. He oversees several tertiary referral cancer centers.
Dr. Alrawi holds both American and British board certifications. He completed fellowships at Roswell Park Cancer Institute. He has previously led oncology divisions at Al Zahra Hospital, Tawam Hospital (a Johns Hopkins affiliate), and 21st Century Oncology in Florida. Dr. Alrawi has published widely and given many invited talks. He remains active in oncology research and education.